Skip Navigation

Cardiovascular Research 2004 61(2):297-306; doi:10.1016/j.cardiores.2003.11.027
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nikolaidis, L. A
Right arrow Articles by Shannon, R. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nikolaidis, L. A
Right arrow Articles by Shannon, R. P
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy

Lazaros A Nikolaidisa, Anthony Sturzua, Carol Stolarskia, Dariush Elahib, You-Tang Shenc and Richard P Shannona,*

aCardiovascular Research Institute and the Department of Medicine, Allegheny General Hospital, 320 East North Ave., Pittsburgh, PA 15212, USA
bUniversity of Massachusetts Medical Center, Worcester, MA 02114, USA
cMerck Research Laboratories, West Point, PA 19486, USA

* Corresponding author. Tel.: +1-412-359-3022; fax: +1-412-359-8152. rshannon{at}wpahs.org

Background: The failing heart demonstrates a preference for glucose as its metabolic substrate. Advanced, severe DCM is characterized by depletion of adenosine triphosphate (ATP) stores, which may be a consequence of impaired insulin mediated glucose uptake and oxidation at a time when the myocardium prefers glucose as its substrate. We examined the time course and magnitude of myocardial insulin resistance during the evolution of dilated cardiomyopathy. Methods and results: Thirty-four conscious, chronically instrumented dogs were studied at four stages during the evolution of dilated cardiomyopathy (DCM) induced by rapid RV pacing [control, early, late and advanced severe]. Transmyocardial glucose, lactate, and non-esterified fatty acid (NEFA) concentrations were measured in the fasting state. The cellular insulin signaling cascade and ATP levels were measured on myocardial samples. NEFA and insulin concentrations increased early and progressively in DCM in association with increased norepinephrine concentrations and progressive hemodynamic impairment. In advanced DCM but not earlier stages, myocardial ATP levels were decreased by 34%. There was decreased myocardial glucose uptake evident under both basal (–29±5%) and insulin stimulated (–32±4%) conditions in advanced, severe DCM, associated with a 31% reduction in GLUT-4 translocation. Importantly, there were no alterations in proximal steps in insulin signaling, but significant reductions in serine (Ser473) phosphorylation of Akt-1. Conclusions: Advanced, severe DCM is associated with the development of myocardial insulin resistance. There is impaired myocardial glucose uptake and altered myocardial insulin signaling, involving decreased Ser 473 phosphorylation of Akt-1. Myocardial insulin resistance in advanced, severe DCM was also associated with reduced myocardial ATP levels.

KEYWORDS Insulin resistance; NEFA; Norepinephrine; Dilated cardiomyopathy; Akt-1; GLUT-4


Time for primary review 00 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. A. ALZadjali, V. Godfrey, F. Khan, A. Choy, A. S. Doney, A. K. Wong, J. R. Petrie, A. D. Struthers, and C. C. Lang
Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure.
J. Am. Coll. Cardiol., March 3, 2009; 53(9): 747 - 753.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
L. Sacca
Heart Failure as a Multiple Hormonal Deficiency Syndrome
Circ Heart Fail, March 1, 2009; 2(2): 151 - 156.
[Full Text] [PDF]


Home page
CirculationHome page
H. Tuunanen, E. Engblom, A. Naum, K. Nagren, M. Scheinin, B. Hesse, K.E. Juhani Airaksinen, P. Nuutila, P. Iozzo, H. Ukkonen, et al.
Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy
Circulation, September 16, 2008; 118(12): 1250 - 1258.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M. R. Martins, A. K. G. Vieira, E. P. G. de Souza, and A. S. Moura
Early overnutrition impairs insulin signaling in the heart of adult Swiss mice
J. Endocrinol., September 1, 2008; 198(3): 591 - 598.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
I. Poornima, S. B. Brown, S. Bhashyam, P. Parikh, H. Bolukoglu, and R. P. Shannon
Chronic Glucagon-Like Peptide-1 Infusion Sustains Left Ventricular Systolic Function and Prolongs Survival in the Spontaneously Hypertensive, Heart Failure-Prone Rat
Circ Heart Fail, September 1, 2008; 1(3): 153 - 160.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.